MedPath

Systemic Steroids Plus Antibiotics in Sleep Apnea Syndrome in Children

Phase 4
Terminated
Conditions
Obstructive Sleep Apnea Syndrome
Registration Number
NCT00456339
Lead Sponsor
University of Chicago
Brief Summary

The purpose of this study is to investigate the effect of treatment with a steroid and antibiotic on the size of the tonsils and symptoms of children with OSAS.

Detailed Description

We will enroll children between 18 months and 12 years of age with mild sleep apnea and treat them with 5 days of prednisolone and 10 days of amoxicillin/clavulanate. We will obtain a questionnaire pre and post treatment and ask the parents to tell us if they think the child has improved enough after treatment to forego surgery. If not, they will undergo an adenotonsillectomy to relieve their sleep apnea and if yes, we will repeat the sleep study to make sure that the apnea has resolved.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
4
Inclusion Criteria
  • Polysomnogram results showing mild obstructive sleep apnea.
Exclusion Criteria
  • Significant medical problems
  • Chronic medication intake (except bronchodilators and inhaled steroids)
  • Allergy to penicillin or its derivatives.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Sleep apnea questionnaire1-2 weeks post treatment
Size of tonsilsbefore and after treatment
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Chicago

🇺🇸

Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath